These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33766921)

  • 1. Asthma: a disease of variability.
    Congleton J
    Drug Ther Bull; 2021 Apr; 59(4):50. PubMed ID: 33766921
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatric Severe Asthma in the Era of Biologic Treatments.
    Teague WG
    Pediatr Allergy Immunol Pulmonol; 2020 Sep; 33(3):118-120. PubMed ID: 32953228
    [No Abstract]   [Full Text] [Related]  

  • 3. Asthma biologics: Underuse, overuse, and best use?
    Rank MA; Oppenheimer JJ
    Ann Allergy Asthma Immunol; 2019 Apr; 122(4):358-359. PubMed ID: 30578858
    [No Abstract]   [Full Text] [Related]  

  • 4. Biologic Targeting: New and Effective Therapeutic Approaches against Severe Asthma.
    Yang X; Feng HR; Chen ZM; Ying SM
    Chin Med J (Engl); 2018 May; 131(9):1009-1012. PubMed ID: 29692369
    [No Abstract]   [Full Text] [Related]  

  • 5. [New guidelines and new therapy options in severe asthma].
    Einecke D
    MMW Fortschr Med; 2016 May; 158(9):18-9. PubMed ID: 27155682
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe asthma, biologicals, and auto-injection: Yes, no, may be!
    Lombardi C; Passalacqua G; Bagnasco D
    Allergy; 2020 Feb; 75(2):444-445. PubMed ID: 31318070
    [No Abstract]   [Full Text] [Related]  

  • 7. Biologics, Clinical Context, and the Asthmas.
    Casale TB; Israel E
    J Allergy Clin Immunol Pract; 2019; 7(5):1437-1439. PubMed ID: 31076059
    [No Abstract]   [Full Text] [Related]  

  • 8. Biologics for paediatric severe asthma: trick or TREAT?
    Saglani S; Bush A; Carroll W; Cunningham S; Fleming L; Gaillard E; Gupta A; Murray C; Nagakumar P; Paton J; Roberts G; Seddon P; Sinha I
    Lancet Respir Med; 2019 Apr; 7(4):294-296. PubMed ID: 30824361
    [No Abstract]   [Full Text] [Related]  

  • 9. [Asthma - Update 2019].
    Powitz F
    MMW Fortschr Med; 2019 Mar; 161(Suppl 1):45-55. PubMed ID: 30912087
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe asthma and biologics: Data are good, listening to patients is better.
    Bukstein DA; Guerra DG
    Ann Allergy Asthma Immunol; 2021 Sep; 127(3):285-286. PubMed ID: 34479728
    [No Abstract]   [Full Text] [Related]  

  • 11. Biologics in severe asthma: Which one, When and Where?
    Rupani H; Murphy A; Bluer K; Renwick C; McQuitty P; Jackson DJ; Heaney LG; Chaudhuri R; Menzies-Gow A; Calvert J; Siddiqui S
    Clin Exp Allergy; 2021 Sep; 51(9):1225-1228. PubMed ID: 34289191
    [No Abstract]   [Full Text] [Related]  

  • 12. Understanding the response to asthma biological therapy.
    Roberts G
    Clin Exp Allergy; 2020 Sep; 50(9):992-993. PubMed ID: 32902035
    [No Abstract]   [Full Text] [Related]  

  • 13. Selection of Biologics in Severe Asthma: A Multifaceted Algorithm.
    Dávila I; Quirce S; Olaguibel JM
    J Investig Allergol Clin Immunol; 2019; 29(4):325-328. PubMed ID: 30969172
    [No Abstract]   [Full Text] [Related]  

  • 14. New Treatments for Asthma.
    Huang J; Pansare M
    Pediatr Clin North Am; 2019 Oct; 66(5):925-939. PubMed ID: 31466682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When to stop biologicals. Severe asthma exacerbation after mepolizumab discontinuation.
    Bagnasco D; Aloè T; Sclifò F; Ferrantino MG; Marugo F; Arcadipane F; Manfredi A; Canonica GW; Passalacqua G
    Eur Ann Allergy Clin Immunol; 2019 May; 51(3):135-137. PubMed ID: 31081606
    [No Abstract]   [Full Text] [Related]  

  • 16. What is the current role of biologics in the management of patients with severe refractory asthma?
    Draikiwicz S; Oppenheimer J
    Ann Allergy Asthma Immunol; 2016 May; 116(5):383-7. PubMed ID: 27153737
    [No Abstract]   [Full Text] [Related]  

  • 17. Going Beyond "Bio-markers," Think "Life-markers".
    Tan L; Chupp G; Castro M; Kraft M
    Chest; 2020 Mar; 157(3):503-505. PubMed ID: 32145809
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined approach to define the clinical impact and decision making in asthmatics.
    Clini E; Fabbri LM
    Minerva Med; 2021 Oct; 112(5):539-541. PubMed ID: 34814632
    [No Abstract]   [Full Text] [Related]  

  • 19. The challenge of choosing the correct biologic for the correct asthma patient.
    Sriaroon P; Casale TB
    Ann Allergy Asthma Immunol; 2018 Oct; 121(4):385-386. PubMed ID: 30290891
    [No Abstract]   [Full Text] [Related]  

  • 20. Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.
    Huffaker MF; Phipatanakul W
    Immunol Allergy Clin North Am; 2015 Feb; 35(1):129-44. PubMed ID: 25459581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.